Imatinib plasma trough concentration and its correlation with characteristics and response in Chinese CML patients.
about
SLC22A1-ABCB1 haplotype profiles predict imatinib pharmacokinetics in Asian patients with chronic myeloid leukemia.Clinical efficacy and safety of imatinib in the management of Ph(+) chronic myeloid or acute lymphoblastic leukemia in Chinese patients.An economic analysis of high-dose imatinib, dasatinib, and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China: A CHEERS-compliant article.Pharmacology and pharmacokinetics of imatinib in pediatric patients.Trough concentration and ABCG2 polymorphism are better to predict imatinib response in chronic myeloid leukemia: a meta-analysis.
P2860
Imatinib plasma trough concentration and its correlation with characteristics and response in Chinese CML patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Imatinib plasma trough concent ...... ponse in Chinese CML patients.
@ast
Imatinib plasma trough concent ...... ponse in Chinese CML patients.
@en
Imatinib plasma trough concent ...... ponse in Chinese CML patients.
@nl
type
label
Imatinib plasma trough concent ...... ponse in Chinese CML patients.
@ast
Imatinib plasma trough concent ...... ponse in Chinese CML patients.
@en
Imatinib plasma trough concent ...... ponse in Chinese CML patients.
@nl
prefLabel
Imatinib plasma trough concent ...... ponse in Chinese CML patients.
@ast
Imatinib plasma trough concent ...... ponse in Chinese CML patients.
@en
Imatinib plasma trough concent ...... ponse in Chinese CML patients.
@nl
P2093
P2860
P356
P1476
Imatinib plasma trough concent ...... ponse in Chinese CML patients.
@en
P2093
Hong-xiang Wang
Qiu-bai Li
Yan-lin Wu
Zhi-chao Chen
P2860
P2888
P304
P356
10.1038/APS.2010.79
P577
2010-07-19T00:00:00Z
P5875
P6179
1013769270